- Home
- WABC vs CVAC Comparison
WABC vs CVAC Comparison
Compare WABC & CVAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WABC
- CVAC
- Stock Information
- Founded
- WABC 1972
- CVAC 2000
- Country
- WABC United States
- CVAC Germany
- Employees
- WABC N/A
- CVAC N/A
- Industry
- WABC Major Banks
- CVAC Biotechnology: Pharmaceutical Preparations
- Sector
- WABC Finance
- CVAC Health Care
- Exchange
- WABC Nasdaq
- CVAC Nasdaq
- Market Cap
- WABC 1.2B
- CVAC 1.2B
- IPO Year
- WABC N/A
- CVAC 2020
- Fundamental
- Price
- WABC $50.20
- CVAC $5.38
- Analyst Decision
- WABC Hold
- CVAC Hold
- Analyst Count
- WABC 2
- CVAC 3
- Target Price
- WABC $52.00
- CVAC $6.83
- AVG Volume (30 Days)
- WABC 137.0K
- CVAC 629.1K
- Earning Date
- WABC 10-16-2025
- CVAC 08-15-2025
- Dividend Yield
- WABC 3.67%
- CVAC N/A
- EPS Growth
- WABC N/A
- CVAC N/A
- EPS
- WABC 4.79
- CVAC 1.01
- Revenue
- WABC $274,792,000.00
- CVAC $599,540,810.00
- Revenue This Year
- WABC N/A
- CVAC N/A
- Revenue Next Year
- WABC N/A
- CVAC $24.04
- P/E Ratio
- WABC $10.47
- CVAC $5.34
- Revenue Growth
- WABC N/A
- CVAC 675.15
- 52 Week Low
- WABC $42.00
- CVAC $2.37
- 52 Week High
- WABC $59.97
- CVAC $5.72
- Technical
- Relative Strength Index (RSI)
- WABC 55.82
- CVAC 46.15
- Support Level
- WABC $49.46
- CVAC $5.36
- Resistance Level
- WABC $50.75
- CVAC $5.48
- Average True Range (ATR)
- WABC 1.04
- CVAC 0.05
- MACD
- WABC 0.17
- CVAC -0.02
- Stochastic Oscillator
- WABC 76.08
- CVAC 11.11
About WABC Westamerica Bancorporation
Westamerica Bancorp is based in San Rafael, California. Westamerica Bancorporation runs a regional community bank and has approximately $7.5 billion in assets. The banks' net revenue is generated by net interest income. Deposit service charges make up the noninterest income sources. The bank focuses mostly on commercial clients, such as smaller businesses. Its footprint encompasses central and northern California, extending north of San Francisco to Mendocino and Lake counties, south to Kern County in central California and all the way east to Nevada County.
About CVAC CureVac N.V.
CureVac NV is a biopharmaceutical company headquartered in Germany that is developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA) that has the potential to improve the lives of people. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and COVID-19 vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.